Patients who develop polyneuropathy associated with sensorineural hearing loss and optic atrophy during childhood, with an X‐linked inheritance, such as Patient IV, should be assessed for PRPS1. PRPS1 pathogenic variants lead to CMTX5, a rare condition with only seven variants already reported. This evidence concerns the gene PRPS1 and hearing loss disorder.